ArticleBlood advances2025

Survival after anti-CD19 CAR T-cell therapy for B-cell non-Hodgkin lymphoma and CLL with 10 years of follow-up.

Tatyana Gavrilova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.